This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Learn About Coagulation Disorders
-What are Bleeding Disorders?
 History of Bleeding Disorders
-Types of Bleeding Disorders
 Hemophilia A
 Hemophilia B
 von Willebrand Disease
-Other Factor Deficiencies
 Factor I
 Factor II
 Factor V
 Factor VII
 Factor X
 Factor XI
-Factor XII
 Factor XIII
 Types of Bleeds
 Bleeding Disorders and Women
 Caring for the Newly Diagnosed Child
 Psychosocial Issues
 Complications, including Inhibitors
 Future Therapies
 What are Clotting Disorders?
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Medical and Scientific Advisory Council
 Financial and Insurance Issues
 HANDI, NHF's Information Resource Center
 Web Links



Factor XII Deficiency

(Can also be known as Hageman factor deficiency)

This somewhat mysterious deficiency was first discovered in 1955 and named after John Hageman, the first patient diagnosed with the condition.  The incidence of Factor XII deficiency is estimated at 1 in 1 million.  This deficiency is inherited in an autosomal recessive fashion, which means it affects men and women equally.  It has been reported that factor XII levels seem to be lower among Asians, than any other ethnic group. 

The mystery of Factor XII centers on how the protein is a step in the process of forming  a clot, but people with the deficiency usually do not experience bleeds and normally do not require treatment.  Having a low factor XII level has little to no clinical significance. 

Even with major surgery, bleeding manifestations are extremely rare.  In fact, most people only get diagnosed by chance, or during pre-screening blood tests for surgery.  Since bleeding time is usually normal, diagnosis is made by a prolonged activated partial thromboplastin time (aPTT) test.  A specific factor XII assay is necessary to confirm the initial diagnosis.    


Treatment is usually unnecessary.  There is some indication that Factor XII deficiency may predispose people to thrombosis, but this has not been clearly established


This section of our Web site is sponsored by: